ADHD and Suicide Risk: The Overlooked Roles of Comorbid Disorders and Stimulant Medications.

IF 2.4 Q3 CLINICAL NEUROLOGY
Yaakov Ophir
{"title":"ADHD and Suicide Risk: The Overlooked Roles of Comorbid Disorders and Stimulant Medications.","authors":"Yaakov Ophir","doi":"10.36131/cnfioritieditore20250308","DOIUrl":null,"url":null,"abstract":"<p><p>Does Attention Deficit Hyperactivity Disorder (ADHD) increase the risk of suicidality among children? This article critically examines a notable study by Shahnovsky et al. (2024), which identifies hyperactivity as a significant predictor of suicide attempts. A detailed analysis of the study reveals three critical gaps: (1) oversight of key risk factors, such as ADHD medications and comorbid disorders - some of which were examined in a related study by the same authors, showing no significant association between ADHD and suicidality; (2) misinterpretation of prior research, inaccurately presenting ADHD medications as protective despite evidence indicating a significantly elevated suicide risk among users; and (3) misrepresentation of the study's findings, which largely suggested that ADHD was unrelated to suicide risk based on both parent and child reports and the two examined components of ADHD. Drawing on an extensive body of research, it is argued that depressive symptoms and suicidal ideation are more likely attributable to the first-line treatments for ADHD than to the diagnosis itself. By situating the study within the broader literature, this article cautions against potential real-life implications arising from its conclusions, such as clinicians prescribing ADHD medications to suppress the allegedly dangerous hyperactivity - medications that may paradoxically increase the risk of suicide. This critique is offered with the utmost respect for the authors' lifelong dedication to advancing suicide prevention, with the sincere aim of fostering a constructive dialogue to deepen our understanding of the tragic phenomenon of childhood suicide.</p>","PeriodicalId":46700,"journal":{"name":"Clinical Neuropsychiatry","volume":"22 3","pages":"253-258"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12302815/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropsychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36131/cnfioritieditore20250308","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Does Attention Deficit Hyperactivity Disorder (ADHD) increase the risk of suicidality among children? This article critically examines a notable study by Shahnovsky et al. (2024), which identifies hyperactivity as a significant predictor of suicide attempts. A detailed analysis of the study reveals three critical gaps: (1) oversight of key risk factors, such as ADHD medications and comorbid disorders - some of which were examined in a related study by the same authors, showing no significant association between ADHD and suicidality; (2) misinterpretation of prior research, inaccurately presenting ADHD medications as protective despite evidence indicating a significantly elevated suicide risk among users; and (3) misrepresentation of the study's findings, which largely suggested that ADHD was unrelated to suicide risk based on both parent and child reports and the two examined components of ADHD. Drawing on an extensive body of research, it is argued that depressive symptoms and suicidal ideation are more likely attributable to the first-line treatments for ADHD than to the diagnosis itself. By situating the study within the broader literature, this article cautions against potential real-life implications arising from its conclusions, such as clinicians prescribing ADHD medications to suppress the allegedly dangerous hyperactivity - medications that may paradoxically increase the risk of suicide. This critique is offered with the utmost respect for the authors' lifelong dedication to advancing suicide prevention, with the sincere aim of fostering a constructive dialogue to deepen our understanding of the tragic phenomenon of childhood suicide.

ADHD和自杀风险:合并症和兴奋剂药物被忽视的作用。
注意缺陷多动障碍(ADHD)会增加儿童自杀的风险吗?本文批判性地考察了Shahnovsky等人(2024)的一项著名研究,该研究认为多动症是自杀企图的重要预测因素。对该研究的详细分析揭示了三个关键的差距:(1)对关键风险因素的监督,如ADHD药物和共病障碍——其中一些在同一作者的相关研究中被检查过,显示ADHD和自杀之间没有显著关联;(2)对先前研究的误解,不准确地将ADHD药物描述为具有保护作用的药物,尽管有证据表明ADHD药物使用者的自杀风险显著增加;(3)歪曲研究结果,根据父母和孩子的报告以及ADHD的两个检查组成部分,该研究结果在很大程度上表明ADHD与自杀风险无关。根据广泛的研究,人们认为抑郁症状和自杀意念更可能归因于多动症的一线治疗,而不是诊断本身。通过将这项研究置于更广泛的文献中,这篇文章对其结论可能产生的现实生活影响提出了警告,比如临床医生开ADHD药物来抑制所谓的危险的多动——这些药物可能会自相矛盾地增加自杀的风险。作者一生致力于促进自杀预防,真诚的目的是促进建设性的对话,加深我们对儿童自杀悲剧现象的理解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Neuropsychiatry
Clinical Neuropsychiatry CLINICAL NEUROLOGY-
CiteScore
11.10
自引率
1.60%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信